[ALNY] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
14-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- 13.80%
YoY- -48.66%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 258,535 163,562 71,681 21,033 37,924 17,454 7,551 80.10%
PBT -260,302 -243,599 -276,583 -211,080 -142,227 -112,934 -90,721 19.18%
Tax -1,842 -59 -398 361 -7,949 -5,217 -6,685 -19.31%
NP -258,460 -243,540 -276,185 -211,441 -142,227 -112,934 -90,721 19.04%
Tax Rate - - - - - - - -
Total Cost 516,995 407,102 347,866 232,474 180,151 130,388 98,272 31.84%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -99.97 -148.90 -385.30 -1,005.28 -375.03 -647.04 -1,201.44 -33.90%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -2.16 -2.09 -2.47 -2.09 -1.48 -1.32 -1.07 12.40%
EPS Diluted -2.16 -2.09 -2.47 -2.09 -1.48 -1.32 -1.07 12.40%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.